United Cannabis Corporation was formed to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible.
The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to implement and monitor effective therapy protocols. Prana Bio Nutrient Medicinals offer patients and physicians a full spectrum cannabinoid sequencing program available in micro-dosing sublingual drops or capsule formulations.
Since 2014, United Cannabis Corp began publicly trading on the OTCBB under the symbol CNAB. The Company partners with industry leaders in legal US territories and abroad for the purpose of promoting best practices in planning, procedures, governance and patient care. For more information visit our investor page.